LAUSANNE, Switzerland — Spinomix SA, a Swiss company advancing molecular diagnostic through innovative sample preparation technologies and Debiopharm Group™(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the successful achievement of a second development milestone on Spinomix’ two proprietary technologies, namely […]

Minneapolis, Minnesota – Techne Corporation (NASDAQ: TECH) today announced that Gregory J. Melsen will resign from his position as Chief Financial Officer, effective February 3, 2014, to pursue other opportunities. Mr. Melsen has served as Techne’s Chief Financial Officer since 2004. Techne has begun the process of identifying a successor to Mr. Melsen and expects […]

After 19 years at the top of Endress+Hauser, Klaus Endress is set to clear his desk at the office in Reinach, Switzerland. The previous CEO moves to the Group’s Supervisory Board as of 1 January 2014, replacing President Klaus Riemenschneider who is retiring after 43 years of work for Endress+Hauser. New CEO of the Group […]

SANTA CLARA, Calif.- Agilent Technologies Inc. (NYSE: A) today announced that Fred Strohmeier, vice president and general manager of Agilent’s Life Science Products and Solutions, has been named senior vice president, Agilent, and president of Agilent’s Life Sciences and Diagnostics Group (LDG), effective immediately. Strohmeier has been in charge of Agilent’s life sciences business, the […]

Hercules, CA —— Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that Robert M. Malchione has been appointed to its Board of Directors effective January 1, 2014. Mr. Malchione will stand for election to the Board along with Bio-Rad’s other directors […]

CAMBRIDGE, England–Sphere Fluidics Limited has developed unique technology for single cell analysis and characterization and provides proprietary products and novel services for this rapidly-growing market. This enabling approach can find rare variants in large cell populations and Sphere Fluidics has patented novel Cyto-Mine™ technology that permits up to one billion assays per biochip per day. […]

Oberkochen, Germany — The start of calendar year 2014 will see some changes to the Executive Board of Carl Zeiss AG headed by President and CEO Dr. Michael Kaschke. The enlargement of the Executive Board and the reallocation of responsibilities are aimed at driving forward the consistent positioning of ZEISS as a portfolio company in […]

Jena, Germany — Analytik Jena AG has appointed Dr. Marco Tilgner as the new managing director of the Japanese subsidiary AJ Japan as of January 1, 2014. Mr. Tilgner, who will report in his future role to Analytik Jena Chief Executive Officer Klaus Berka, already took over responsibility for finance and administration at the subsidiary […]

MILFORD, Mass.—- Waters Corporation (NYSE:WAT) today announced that John Ornell, its Chief Financial Officer, has communicated his intention to transition to a reduced workload and resign as the Company’s Chief Financial Officer effective February 1, 2014. Mr. Ornell will then continue to serve the Company in an advisory capacity on a part-time basis. The Board […]

SALT LAKE CITY — Dr. Mingfu Zhu, previously of the Duke Center for Human Genome Variation, has announced his new position with Tute Genomics as Director of Bioinformatics. Dr. Zhu’s extensive work with structural variation analysis of next-generation sequencing (NGS) data from whole genomes places Tute ahead of other analytic engines in applying structural variant […]